Valeur20202021202220232024Total du passif36.39 M35.88 M35.5 M34.11 M39.55 MTotal des capitaux propres57.15 M32.19 M15.3 M5.42 M-865 KTotal du passif et des capitaux propres93.54 M68.06 M50.8 M39.53 M38.68 MDette totale23.85 M21.68 M23.53 M24.03 M27.29 MDette nette-64.37 M11.91 M18.17 M-6.85 M5.38 M
Pluri Inc. - Common Stock
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.